welcome
The Motley Fool

The Motley Fool

Business

Business & Economics

Three of the best stocks to buy right now: Eli Lilly, Novo Nordisk, and more

The Motley Fool
Summary
Nutrition label

61% Informative

Three Fool contributors think there are some unstoppable stocks you can buy right now without hesitation.

Eli Lilly is a growth beast with plenty of upside.

Novo Nordisk is not far from its 52-week low.

Vertex Pharmaceuticals is helping patients (and investors) breathe easier.

The biotech company now has three promising new products on the market.

Casgevy , the first approved CRISPR gene-editing therapy, is picking up momentum in treating sickle cell disease and transfusion-dependent beta-thalassemia.

Vertex also won FDA approval in January for Journavx , a non-opioid targeting acute pain.

VR Score

52

Informative language

53

Neutral language

8

Article tone

semi-formal

Language

English

Language complexity

50

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

medium-lived

Source diversity

1

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.